These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


599 related items for PubMed ID: 16965416

  • 1. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
    Körver JE, van Duijnhoven MW, Pasch MC, van Erp PE, van de Kerkhof PC.
    Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ, Seyger MM, Van de Kerkhof PC.
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [Abstract] [Full Text] [Related]

  • 5. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
    van Lingen RG, Poll MK, Seyger MM, de Jong EM, van de Kerkhof PC, van Erp PE.
    Arch Dermatol Res; 2008 Nov; 300(10):561-7. PubMed ID: 18496701
    [Abstract] [Full Text] [Related]

  • 6. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis.
    Mommers JM, van Rossum MM, van Erp PE, van De Kerkhof PC.
    Dermatology; 2000 Nov; 201(1):15-20. PubMed ID: 10971053
    [Abstract] [Full Text] [Related]

  • 7. Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin.
    Gerritsen MJ, Elbers ME, de Jong EM, van de Kerkhof PC.
    J Dermatol Sci; 1997 Mar; 14(3):179-88. PubMed ID: 9138475
    [Abstract] [Full Text] [Related]

  • 8. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
    Mommers JM, Goossen JW, van De Kerkhof PC, van Erp PE.
    Cytometry; 2000 Feb 15; 42(1):43-9. PubMed ID: 10679742
    [Abstract] [Full Text] [Related]

  • 9. Novel quantitative immunofluorescent technique reveals improvements in epidermal cell populations after mild treatment of psoriasis.
    van Duijnhoven MW, Hagenberg R, Pasch MC, van Erp PE, van de Kerkhof PC.
    Acta Derm Venereol; 2005 Feb 15; 85(4):311-7. PubMed ID: 16191851
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation.
    Körver JE, Vissers WH, van Rens DW, Pasch MC, van Erp PE, Boezeman JB, van De Kerkhof PC.
    Br J Dermatol; 2007 Jan 15; 156(1):130-7. PubMed ID: 17199579
    [Abstract] [Full Text] [Related]

  • 11. Transition from symptomless to lesional psoriatic skin.
    Van de Kerkhof PC, Gerritsen MJ, de Jong EM.
    Clin Exp Dermatol; 1996 Sep 15; 21(5):325-9. PubMed ID: 9136148
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
    van Erp PE, Rijzewijk JJ, Boezeman JB, Leenders J, de Mare S, Schalkwijk J, van de Kerkhof PC, Ramaekers FC, Bauer FW.
    Am J Pathol; 1989 Nov 15; 135(5):865-70. PubMed ID: 2479273
    [Abstract] [Full Text] [Related]

  • 13. Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.
    van Duijnhoven MW, Körver JE, Vissers WH, van Vlijmen-Willems IM, Pasch MC, van Erp PE, Van de Kerkhof PC.
    J Eur Acad Dermatol Venereol; 2006 Jan 15; 20(1):27-33. PubMed ID: 16405604
    [Abstract] [Full Text] [Related]

  • 14. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
    Smit JV, de Jong EM, van Hooijdonk CA, Otero ME, Boezeman JB, van de Kerkhof PC.
    J Am Acad Dermatol; 2004 Aug 15; 51(2):257-64. PubMed ID: 15280845
    [Abstract] [Full Text] [Related]

  • 15. Nature of cell kinetics in psoriatic epidermis.
    Doger FK, Dikicioglu E, Ergin F, Unal E, Sendur N, Uslu M.
    J Cutan Pathol; 2007 Mar 15; 34(3):257-63. PubMed ID: 17302610
    [Abstract] [Full Text] [Related]

  • 16. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
    Bhawan J, Bansal C, Whren K, Schwertschlag U, IL-11 Psoriasis Study Group.
    J Cutan Pathol; 2004 Aug 15; 31(7):471-6. PubMed ID: 15239676
    [Abstract] [Full Text] [Related]

  • 17. Monitoring hyperproliferative disorders in human skin: flow cytometry of changing cytokeratin expression.
    Franssen ME, Boezeman JB, Van De Kerkhof PC, Van Erp PE.
    Cytometry B Clin Cytom; 2004 Jan 15; 57(1):32-9. PubMed ID: 14696061
    [Abstract] [Full Text] [Related]

  • 18. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
    Castelijns FA, Gerritsen MJ, van Vlijmen-Willems IM, van Erp PE, van de Kerkhof PC.
    J Am Acad Dermatol; 1999 Jun 15; 40(6 Pt 1):901-9. PubMed ID: 10365920
    [Abstract] [Full Text] [Related]

  • 19. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.
    Wei L, Debets R, Hegmans JJ, Benner R, Prens EP.
    J Pathol; 1999 Feb 15; 187(3):358-64. PubMed ID: 10398092
    [Abstract] [Full Text] [Related]

  • 20. Markers for proliferation and keratinization in the margin of the active psoriatic lesion.
    de Mare S, de Jong E, Van Erp PE, Van de Kerkhof PC.
    Br J Dermatol; 1990 Apr 15; 122(4):469-75. PubMed ID: 1692474
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.